US: +1-800-981-5864CA: +1-647-370-8281AU: +61-48-207-5486UK: +44-20-3835-4834FR: +33-64-463-9941ES: +34-51-889-9156NZ: +64-80-074-8315DK: +45-52-51-72-02SE: +46-77-421-88-58CH: +41-43-508-24-74CZ: +420-228-885-478FI: +358-9-4245-3635GR: +30-21-1199-2166PT: +351-923-294-983DE: +49-162-664-6525IT: +39-350-850-7594NL: +31-970-102-87367
Kisqali
Ribociclib

Kisqali

Back to catalog

Kisqali (ribociclib) is a targeted medicine used to treat hormone receptor-positive (HR+), HER2-negative [HR+ HER2-] breast cancer, specifically for early-stage (high-risk) or advanced/metastatic cases. It is taken in combination with endocrine therapy (aromatase inhibitors or fulvestrant) to block cancer cell growth.

Active ingredient
Ribociclib

Kisqali 200mg

3 packs
PackagePer PillSpecial Price
5 pills
Free Express Delivery
$117.00
$965.00 -40%
Only $585.00
3 pills
Free Express Delivery
$129.67
$579.00 -33%
Only $389.00
1 pills
$193.00
Only $193.00
You May Also Like
-87% Viagra Viagra Sildenafil $0.24-73% Cialis Cialis Tadalafil $0.62-75% Levitra Levitra Vardenafil $1.00-50% Ozempic (Generic) Ozempic (Generic) Semaglutide $214.00-27% Rybelsus Rybelsus Semaglutide $18.33 Trial ED Pack Trial ED Pack Sildenafil, Tadalafil, Vardenafil $4.00


Kisqali is a targeted therapy used to treat hormone receptor-positive (HR+), HER2-negative (HER2-) breast cancer, specifically for advanced or metastatic cases or early-stage (II or III) high-risk cases. It is a CDK4/6 inhibitor that blocks proteins encouraging cancer growth.